great post.
again , finance situation will be sorted. no1 wants to lose money or to be heavily diluted. those in power in the company will find a way to minimize the affect. something has to be in the winds.
whenever in doubt , read through the cv's of management and board. for a small cap , we have a very strong group running the company.
http://files.shareholder.com/downloads/AMDA-1W04O2/0x0xS1104659-15-70306/1506492/filing.pdf
the data and the progress were making has been brilliant.
enrollments issue and finance uncertainty ( due to the pause ) took us to these levels.
add to it the markets are all down and biotech in general.
nasdaq falling 2% on most days lately
a buy more than ever.
I wonder who the new ceo will be ? or will it be announced after everything is sorted.
nonetheless , barring any unforseen or unmentioned info , we are on our way to something big.
lets hope were rewarded for our patience.
